Legend Biotech (LEGN) Net Income (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 77.90% |
| Sep 30, 2025 | 69.04% |
| Jun 30, 2025 | -223.09% |
| Mar 31, 2025 | 84.15% |
| Dec 31, 2024 | 147.06% |
| Sep 30, 2024 | -556.28% |
| Jun 30, 2024 | -129.68% |
| Mar 31, 2024 | 40,281.85% |
| Dec 31, 2023 | 99.76% |
| Sep 30, 2023 | 68.38% |
| Jun 30, 2023 | -277.12% |
| Mar 31, 2023 | 182.69% |
| Dec 31, 2022 | -60.15% |
| Sep 30, 2022 | 56.12% |
| Jun 30, 2022 | -503.55% |
| Mar 31, 2022 | 62.27% |
| Dec 31, 2021 | 32.09% |
| Sep 30, 2021 | -36.22% |
| Jun 30, 2021 | -92,702.35% |
| Mar 31, 2021 | 99.83% |
| Dec 31, 2020 | 14.62% |
| Sep 30, 2020 | 49.91% |
| Jun 30, 2020 | -181.36% |
| Mar 31, 2020 | 19.33% |
| Dec 31, 2019 | -113.81% |
| Sep 30, 2019 | 1.20% |